tiprankstipranks
Oncternal Therapeutics Inc (ONCT)
NASDAQ:ONCT
US Market
Holding ONCT?
Track your performance easily

Oncternal Therapeutics (ONCT) Income Statement

466 Followers

Oncternal Therapeutics Income Statement

Last quarter (Q3 2024), Oncternal Therapeutics's total revenue was $494.00K, an increase of Infinity% from the same quarter last year. In Q3, Oncternal Therapeutics's net income was $-8.46M. See Oncternal Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 2.45M$ 785.00K$ 1.49M$ 4.32M$ 3.38M$ 2.42M
Cost of Revenue
------
Gross Profit
$ 2.27M$ 785.00K$ 1.49M$ 4.32M$ 3.38M$ 2.42M
Operating Expense
$ 37.34M$ 41.71M$ 44.95M$ 35.68M$ 20.92M$ -35.53M
Operating Income
$ -35.96M$ -41.71M$ -44.95M$ -31.37M$ -17.54M$ -33.11M
Net Non Operating Interest Income Expense
$ 1.38M$ 2.23M$ 777.00K$ 33.00K$ 16.00K$ 188.00K
Other Income Expense
--$ -9.00K-$ -301.00K$ 1.27M
Pretax Income
$ -34.58M$ -39.48M$ -44.17M$ -31.33M$ -17.18M$ -34.19M
Tax Provision
$ -58.00K$ -58.00K$ -2.82M$ -2.01M$ -1.11M$ -265.00K
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -34.58M$ -39.48M$ -44.17M$ -31.33M$ -17.23M$ -34.19M
Basic EPS
$ -11.63$ -13.43$ -16.80$ -12.80$ -17.00-
Diluted EPS
$ -11.63$ -13.43$ -16.80$ -12.80$ -17.00$ -3.31
Basic Average Shares
$ 11.83M$ 2.94M$ 2.63M$ 2.47M$ 1.01K$ 10.33K
Diluted Average Shares
$ 11.83M$ 2.94M$ 2.63M$ 2.47M$ 1.01K$ 10.33M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 19.04M$ 41.71M$ 44.95M$ 35.68M$ 20.92M$ -35.53M
Net Income From Continuing And Discontinued Operation
$ -34.58M$ -39.48M$ -44.17M$ -31.33M$ -17.23M$ -34.19M
Normalized Income
$ -16.85M--$ -33.35M--
Interest Expense
------
EBIT
$ -25.80M$ -41.71M$ -44.95M$ -31.37M$ -17.54M$ -34.19M
EBITDA
$ -25.80M$ -41.71M$ -44.95M$ -31.37M$ -17.54M$ -34.19M
Currency in USD

Oncternal Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis